Maze Therapeutics, Inc. (MAZE)
NASDAQ·Healthcare·Biotechnology
$24.59
-0.93%
Mkt Cap $1.45B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (11 analysts)
$80.50
Range $64.00 – $97.00
Implied Upside
+227.4%
Consensus $80.50 vs current $24.59
NASDAQ·Healthcare·Biotechnology
$24.59
-0.93%
Mkt Cap $1.45B
Buy
5
Hold
0
Sell
0
Price Target (11 analysts)
$80.50
Range $64.00 – $97.00
+227.4%
Consensus $80.50 vs current $24.59